Financing Agreements (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Nov. 30, 2014 |
Nov. 30, 2013 |
Oct. 31, 2013 |
Jul. 31, 2015 |
Oct. 31, 2014 |
Jul. 31, 2014 |
Apr. 30, 2014 |
Apr. 30, 2015 |
Nov. 06, 2013 |
|
| Financing Agreements (Textual) [Abstract] | |||||||||
| Sale leaseback, gain on sale of assets | $ (17,916) | $ (17,915) | |||||||
| Sale leaseback, portion of deferred gain in accrued liabilities | 227,224 | $ 282,284 | |||||||
| Sale leaseback, portion of deferred gain in other long term liabilities | 161,247 | $ 179,163 | |||||||
| Note and Security Agreement | Mr. Sheerr | |||||||||
| Financing Agreements (Textual) [Abstract] | |||||||||
| Sale leaseback transaction, lease terms | The Company entered into an agreement with Mr. Sheerr to leaseback the equipment and furniture that was sold to Mr. Sheerr on October 31, 2013. The lease is for a term of 60 months and the Company is obligated to pay approximately $7,500 per month for the term of the lease. The Company has an option to extend the lease for an additional 2 year period. | ||||||||
| Sale leaseback, monthly rental payments | $ 7,500 | ||||||||
| Sale leaseback, gain on sale of assets | 139,000 | ||||||||
| Sale leaseback, deferred gain | $ 322,000 | ||||||||
| Sale leaseback, portion of deferred gain in accrued liabilities | 72,000 | $ 72,000 | |||||||
| Sale leaseback, portion of deferred gain in other long term liabilities | 161,000 | $ 250,000 | |||||||
| Rosenthal and Rosenthal Financing Agreement | |||||||||
| Financing Agreements (Textual) [Abstract] | |||||||||
| Formula-based secured debt financing capacity | 3,500,000 | $ 3,500,000 | |||||||
| Maturity date | Nov. 30, 2016 | ||||||||
| Financing agreement, amount outstanding | 2,364,000 | ||||||||
| Borrowings, collateral, description | Borrowings under the Financing Agreement are collateralized by substantially all the assets of the Company. | ||||||||
| Interest rate, description | Loans outstanding under the Financing Agreement bear interest at a rate of the Prime Rate (as defined in the Financing Agreement) plus 3.25% (the "Effective Rate") or on Over-advances (as defined in the Financing Agreement), if any, at a rate of the Effective Rate plus 3%. | ||||||||
| Loan facility, borrowing capacity, description | On April 29, 2014, the Company entered into an amendment (the “Amendment”) to the Financing Agreement. The Amendment provides for advances against inventory balances based on prescribed formulas of raw materials and finished goods. | ||||||||
| Credit facility, covenant terms | The Financing Agreement contains other financial and restrictive covenants, including, among others, covenants limiting our ability to incur indebtedness, guarantee obligations, sell assets, make loans, enter into mergers and acquisition transactions and declare or make dividends. | ||||||||
| Additional financing available under the terms of the agreement | 139,000 | ||||||||
| Securities Purchase Agreement | Bridge Notes and Bridge Warrants | |||||||||
| Financing Agreements (Textual) [Abstract] | |||||||||
| Maturity date | Jan. 15, 2016 | Oct. 15, 2014 | |||||||
| Bridge loan | $ 750,000 | ||||||||
| Bridge loan, issuance date | Jul. 15, 2014 | ||||||||
| Bridge loan, conversion description | The sale of shares of its Series A Stock resulted in the reduction of the conversion price of the Bridge Notes held by the institutional investors to $2.00 from $2.50 to equal the conversion price of the Series A Preferred Stock. | The initial conversion price for Institutional Investors is $2.50 per share (which was subsequently reduced), and the initial conversion price for Management is equal to the closing price of the Company’s common stock on the closing date of the Purchase Agreement, $2.94. | |||||||
| Bridge loan, interest rate | 8.00% | ||||||||
| Description of period for exercisability of warrants | The Bridge Warrants are exercisable for five years after the closing date of the Purchase Agreement, or July 15, 2019. For each $1,000 of principal amount of Bridge Notes, the holder received 1,200 Bridge Warrants, each exercisable for the purchase of one share of the Company’s common stock. Each holder is entitled to exercise one-third of all Bridge Warrants received at an exercise price of $3.00, one-third of all Bridge Warrants received at an exercise price of $3.50, and one-third of all Bridge Warrants received at an exercise price that is equal to the closing price on the closing date of the Purchase Agreement, $2.94. | ||||||||
| Sale of Series A preferred stock | 600,000 | ||||||||
| Bridge loan, repayment of debt | 70,000 | ||||||||
| Bridge loan, amount of default | $ 80,000 | ||||||||
| Risk-free interest rate | 1.26% | ||||||||
| Expected volatility | 100.00% | ||||||||
| Expected dividend rate | 0.00% | ||||||||
| Discount on notes payable, warrants | $ 562,000 | ||||||||
| Beneficial conversion feature | 188,000 | ||||||||
| Non-cash interest charge | $ 617,000 | $ 133,000 | |||||||